Stem cell therapy is being investigated as a regenerative approach for female infertility. It may support ovarian function, reproductive health, and complement established fertility treatments in carefully selected patients.
Overview
Female infertility is the inability to achieve pregnancy after 12 months of regular, unprotected intercourse, or after six months for women aged 35 years or older. It may result from reduced ovarian reserve, ovulation disorders, hormonal imbalances, endometriosis, uterine abnormalities, blocked fallopian tubes, or age-related changes in reproductive function. Stem cell therapy is being studied for its potential to support tissue regeneration, improve ovarian health, regulate inflammation, and promote healthy cellular function. Although it is not a cure for infertility or a replacement for assisted reproductive technologies, it may serve as a complementary treatment option for selected women following a comprehensive fertility evaluation.
Female infertility refers to difficulty becoming pregnant due to conditions affecting the ovaries, fallopian tubes, uterus, cervix, or hormonal regulation. Common causes include ovulation disorders such as polycystic ovary syndrome (PCOS), diminished ovarian reserve, endometriosis, uterine fibroids, blocked fallopian tubes, and age-related decline in egg quality. A comprehensive fertility assessment helps identify the underlying cause and guide appropriate treatment.
Traditional fertility treatments include medications to stimulate ovulation, hormone therapy, surgical procedures, intrauterine insemination (IUI), and in vitro fertilization (IVF). Stem cell therapy is being researched as a regenerative approach that aims to support tissue repair, improve cellular function, and create a healthier reproductive environment rather than replacing conventional fertility treatments.
Stem cell therapy is not considered a cure for female infertility, and it cannot guarantee pregnancy. Current research is exploring its potential role in supporting ovarian function and reproductive health in selected patients. Individual outcomes vary depending on the underlying cause of infertility, age, and overall health.
Mesenchymal stromal cells (MSCs) produce growth factors, cytokines, and signaling molecules that may support tissue repair, regulate inflammation, improve blood supply, and promote healthy cellular communication. Researchers continue to investigate whether these regenerative properties may help improve ovarian function and support reproductive health.
Treatment outcomes vary depending on age, ovarian reserve, hormonal status, and the underlying cause of infertility. Some women may experience gradual improvements in reproductive health over several months, while others may continue to require assisted reproductive treatments. Regular monitoring by a fertility specialist remains essential.
Eligibility is determined through a comprehensive fertility assessment. Doctors evaluate ovarian reserve, hormone levels, reproductive history, imaging studies, previous fertility treatments, and overall health before determining whether stem cell therapy may be an appropriate supportive option.
Before treatment, physicians review hormone testing, ultrasound findings, ovarian reserve assessments such as AMH levels, reproductive history, previous pregnancies, medications, and any gynecological conditions. Additional investigations may be recommended to ensure treatment is appropriate and safe.
| Area | Possible Changes |
|---|---|
| Ovarian Function | May support healthier ovarian tissue and reproductive function. |
| Hormonal Balance | May promote healthier reproductive hormone regulation. |
| Ovarian Reserve | May support ovarian health in carefully selected patients. |
| Blood Supply | May improve circulation to reproductive tissues. |
| Inflammation | May reduce inflammation affecting reproductive organs. |
| Reproductive Health | Supports overall female reproductive wellness. |
| Fertility Treatment | May complement IVF, IUI, and other fertility treatments. |
| Quality of Life | May improve emotional well-being throughout fertility care. |
| Factor | Medical Assessment |
|---|---|
| Age | Adult women experiencing infertility may be evaluated individually. |
| Diagnosis | A confirmed diagnosis of female infertility following a comprehensive fertility evaluation is recommended. |
| Overall Health | Candidates should be medically stable and suitable for regenerative treatment. |
| Underlying Cause | Doctors assess ovarian reserve, ovulation disorders, endometriosis, tubal disease, uterine conditions, hormonal disorders, and previous medical history before recommending treatment. |
| Previous Fertility Treatment | Previous medications, surgery, IUI, IVF, or other fertility treatments are reviewed during treatment planning. |
Expected Benefits
Stem cell therapy is being studied as a supportive treatment for menopause. It may help improve overall well-being, support hormonal balance, and reduce certain menopause-related symptoms when used alongside appropriate medical care.
Stem cell therapy is being investigated as a regenerative approach for male infertility. It may support reproductive health, improve testicular function, and complement conventional fertility treatments in selected patients.
Stem cell therapy is being investigated as a regenerative treatment for erectile dysfunction. It may support blood vessel health, tissue repair, and sexual function when combined with appropriate medical care.